October 8, 2026 - News

Outro Health Raises $7M to Rethink Deprescribing

Exit strategy.
Man drawing a graph representing deprescribing
Outro Health

Outro Health is guiding patients through the next step.

What’s happening: The medication deprescribing platform announced $7M to scale its antidepressant tapering programs while expanding into other drugs.

Steady pace. Building a neuroscience-backed off-ramp, Outro combines hyperbolic tapering, regular clinician check-ins, and symptom tracking to help long-term antidepressant users manage withdrawal symptoms like anxiety, insomnia, dizziness and brain zaps. Adapting its pace to patient, not prescription — programs can span up to two years.

Care plan. Addressing America’s overprescription problem, deprescribing is emerging as a missing care layer, with Outro scaling its AI tools and clinician network to make stopping a standard part of the prescription lifecycle.

As Rx for mental health, sleep, ADHD, and weight loss peak, Outro is exploring how its platform can follow — envisioning an “Uber for getting off meds” to fill the gap between starting and stopping.

Punchline: As the treatment toolkit keeps growing, Outro is building the safer exit strategy for a healthcare system focused on the starting point.

Laura Hill
Laura Hill
Strategic intelligence for the future of health.

We break down how fitness, wellness, and healthcare are converging — and what it means for business, culture, and capital.

No thanks.